Guidance for Canadian Breast Cancer Practice : National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2 : Early Breast Cancer 2025

Sehdev, Sandeep, Joy, Anil Abraham, Boileau, Jean-François, Bouganim, Nathaniel, Brezden-Masley, Christine, Cao, Jeffrey Q., Cescon, David W., Chia, Stephen, Edwards, Scott, Gelmon, Karen A., Jerzak, Katarzyna J., Kumar, Aalok, Laing, Kara, LeVasseur, Nathalie, Simmons, Christine, Webster, Marc, Manna, Mita, on behalf of Patient Advocacy, Breast Cancer Canada,

Open source

DOI: 10.14288/1.0451631
Published: 2026
Container: Not recorded
Publisher: Multidisciplinary Digital Publishing Institute
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.14288/1.0451631,
  title = {Guidance for Canadian Breast Cancer Practice : National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2 : Early Breast Cancer 2025},
  author = {Sehdev, Sandeep and Joy, Anil Abraham and Boileau, Jean-François and Bouganim, Nathaniel and Brezden-Masley, Christine and Cao, Jeffrey Q. and Cescon, David W. and Chia, Stephen and Edwards, Scott and Gelmon, Karen A. and Jerzak, Katarzyna J. and Kumar, Aalok and Laing, Kara and LeVasseur, Nathalie and Simmons, Christine and Webster, Marc and Manna, Mita and on behalf of Patient Advocacy, Breast Cancer Canada,},
  year = {2026},
  doi = {10.14288/1.0451631},
  url = {https://doi.org/10.14288/1.0451631}
}

RIS

TY  - JOUR
TI  - Guidance for Canadian Breast Cancer Practice : National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2 : Early Breast Cancer 2025
AU  - Sehdev, Sandeep
AU  - Joy, Anil Abraham
AU  - Boileau, Jean-François
AU  - Bouganim, Nathaniel
AU  - Brezden-Masley, Christine
AU  - Cao, Jeffrey Q.
AU  - Cescon, David W.
AU  - Chia, Stephen
AU  - Edwards, Scott
AU  - Gelmon, Karen A.
AU  - Jerzak, Katarzyna J.
AU  - Kumar, Aalok
AU  - Laing, Kara
AU  - LeVasseur, Nathalie
AU  - Simmons, Christine
AU  - Webster, Marc
AU  - Manna, Mita
AU  - on behalf of Patient Advocacy, Breast Cancer Canada,
PY  - 2026
DO  - 10.14288/1.0451631
UR  - https://doi.org/10.14288/1.0451631
ER  -

APA

Sandeep, S., Abraham, J. A., Jean-François, B., Nathaniel, B., Christine, B., Q., C. J., W., C. D., Stephen, C., Scott, E., A., G. K., J., J. K., Aalok, K., Kara, L., Nathalie, L., Christine, S., Marc, W., Mita, M., & Canada,, O. B. O. P. A. B. C. (2026). Guidance for Canadian Breast Cancer Practice : National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2 : Early Breast Cancer 2025. https://doi.org/10.14288/1.0451631

Source records

datacite · retrieved 2026-09-25T03:19:36.852Z